ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
127 hedge funds and large institutions have $1.69B invested in Alder Biopharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% more funds holding
Funds holding: 89 → 127 (+38)
59% less call options, than puts
Call options by funds: $2.66M | Put options by funds: $6.49M
Holders
127
Holding in Top 10
4
Calls
$2.66M
Puts
$6.49M
Top Buyers
| 1 | +$296M | |
| 2 | +$61.2M | |
| 3 | +$52.2M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$49.5M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$45.7M |
Top Sellers
| 1 | -$66.2M | |
| 2 | -$66.2M | |
| 3 | -$20.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.64M |